A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...
Real-world use of an MS blood test shows how it helps monitor disease activity and guide treatment decisions in U.S. patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results